As of April 2023 Merck has a market cap of $270.08 Billion. This makes Merck the world's 29th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $270.08 B | -3.99% |
2022 | $281.30 B | 45.31% |
2021 | $193.58 B | -6.46% |
2020 | $206.95 B | -10.38% |
2019 | $230.92 B | 16.57% |
2018 | $198.09 B | 29.22% |
2017 | $153.30 B | -5.55% |
2016 | $162.31 B | 10.49% |
2015 | $146.89 B | -8.86% |
2014 | $161.17 B | 10% |
2013 | $146.52 B | 18.25% |
2012 | $123.91 B | 7.84% |
2011 | $114.90 B | 3.45% |
2010 | $111.07 B | -2.2% |
2009 | $113.57 B | 76.71% |
2008 | $64.27 B | -49.09% |
2007 | $126.24 B | 33.57% |
2006 | $94.51 B | 36.18% |
2005 | $69.40 B | -2.22% |
2004 | $70.98 B | -30.84% |
2003 | $102.64 B | -19.46% |
2002 | $127.44 B | -6.04% |
2001 | $135.63 B |
On Apr 1st, 2023 the market cap of Merck was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $483.57 B | 79.05% | ๐บ๐ธ USA |
![]() Novartis NVS | $195.00 B | -27.80% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $231.78 B | -14.18% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $178.72 B | -33.83% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $327.05 B | 21.10% | ๐บ๐ธ USA |
![]() Amgen AMGN | $130.46 B | -51.69% | ๐บ๐ธ USA |
![]() Sanofi SNY | $135.91 B | -49.68% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $145.77 B | -46.02% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $72.84 B | -73.03% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $9.95 B | -96.31% | ๐ฎ๐ฑ Israel |